| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) | 
|---|
| 03/05/2014 | CN103613527A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor | 
| 03/05/2014 | CN102498091B Glycine compound | 
| 03/05/2014 | CN101835757B Diacylglycerol acyltransferase inhibitors | 
| 03/05/2014 | CN101701006B Phenethanolamine derivatives for treatment of respiratory diseases | 
| 03/04/2014 | US8664399 Substituted heterocyclic compounds as ion channel modulators | 
| 03/04/2014 | US8664380 Heterocyclic compound and use thereof | 
| 03/04/2014 | US8664379 Fused heterocyclic compounds as ion channel modulators | 
| 02/27/2014 | WO2014031971A1 Herbicidal pyridazinones | 
| 02/27/2014 | WO2014031936A2 Heterocyclic modulators of hif activity for treatment of disease | 
| 02/27/2014 | WO2014031933A2 Heterocyclic modulators of hif activity for treatment of disease | 
| 02/27/2014 | WO2014031928A2 Heterocyclic modulators of hif activity for treatment of disease | 
| 02/27/2014 | WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections | 
| 02/27/2014 | WO2014030743A1 Heterocycic compound | 
| 02/27/2014 | WO2014030001A1 Fused heterocyclic compounds and their use | 
| 02/27/2014 | WO2014029832A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | 
| 02/27/2014 | WO2014029831A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | 
| 02/27/2014 | WO2014029830A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | 
| 02/27/2014 | WO2014029684A1 Pesticidally active pyridyl- and pyrimidyl- substituted pyrazole derivatives | 
| 02/27/2014 | WO2014029333A1 Substituted oxazolidinone compound and pharmaceutical composition comprising the compound and use thereof | 
| 02/27/2014 | WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals | 
| 02/27/2014 | WO2014029007A1 Protein kinase inhibitors | 
| 02/27/2014 | WO2014008257A3 Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles | 
| 02/27/2014 | US20140058105 Substituted diketopiperazines and their use as oxytocin antagonists | 
| 02/27/2014 | US20140058100 Tetrahydroisoquinolin-1-one derivative or salt thereof | 
| 02/27/2014 | US20140057951 Substituted oxazolidinones and their use | 
| 02/27/2014 | US20140057926 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | 
| 02/27/2014 | US20140057920 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | 
| 02/27/2014 | US20140057916 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | 
| 02/27/2014 | US20140057914 Heterocyclic modulators of hif activity for treatment of disease | 
| 02/27/2014 | US20140057895 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof | 
| 02/27/2014 | US20140057893 Substituted cycloproply compounds, compositions containing such compounds and methods of treatment | 
| 02/27/2014 | US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | 
| 02/27/2014 | US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | 
| 02/27/2014 | US20140057882 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | 
| 02/27/2014 | US20140056880 Triazole compounds as ksp inhibitors | 
| 02/27/2014 | CA2876690A1 Dihydropyrimidine compounds and their application in pharmaceuticals | 
| 02/26/2014 | EP2699580A2 Diazonamide analogs | 
| 02/26/2014 | EP2699568A1 A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation | 
| 02/26/2014 | EP2699567A1 Insulin-like growth factor-1 receptor inhibitors | 
| 02/26/2014 | EP2699566A1 Phenyl-isoxazol derivatives and preparation process thereof | 
| 02/26/2014 | EP2699565A1 Fatty acid amide hydrolase inhibitors for treating pain | 
| 02/26/2014 | EP2699561A1 Androgen receptor modulating carboxamides | 
| 02/26/2014 | EP2699560A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof | 
| 02/26/2014 | EP2699547A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators | 
| 02/26/2014 | CN103608345A Oxazine derivative and BACE 1 inhibitor containing same | 
| 02/26/2014 | CN103608344A [1,3]oxazines | 
| 02/26/2014 | CN103608335A Pyrimidine derivatives for the treatment of viral infections | 
| 02/26/2014 | CN103608332A Pyridin-2-amides useful as CB2 agonists | 
| 02/26/2014 | CN103601724A Novel oxazolidinone compound, as well as preparation method and application thereof | 
| 02/26/2014 | CN103601723A Industrial production method of azilsartan | 
| 02/26/2014 | CN103601674A Compounds for inhibiting dipeptide kininase, preparation method and applications thereof | 
| 02/26/2014 | CN102603724B Method for purifying and refining dimethoxy taxane compound | 
| 02/26/2014 | CN102516237B Oxazolidinone derivative | 
| 02/26/2014 | CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases | 
| 02/26/2014 | CN102099352B STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient | 
| 02/25/2014 | US8658798 Herbicide triazolylpyridine ketones | 
| 02/25/2014 | US8658789 Method for preparing linezolid and intermediates thereof | 
| 02/25/2014 | US8658675 Pyridin-4-yl derivatives | 
| 02/25/2014 | US8658659 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors | 
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use | 
| 02/25/2014 | US8658649 Kinase inhibitor | 
| 02/25/2014 | US8658641 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections | 
| 02/25/2014 | US8658639 N-substituted-cyclic amino derivative | 
| 02/25/2014 | US8658636 TRPV4 antagonists | 
| 02/25/2014 | US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases | 
| 02/25/2014 | CA2777632C Imidazole derivatives as casein kinase inhibitors | 
| 02/22/2014 | CA2787472A1 Protein kinase inhibitors | 
| 02/20/2014 | WO2014028669A1 Novel compounds for modulation of ror-gamma activity | 
| 02/20/2014 | WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions | 
| 02/20/2014 | WO2014028025A1 Compositions and methods for treating myotonic dystrophy type 1 | 
| 02/20/2014 | WO2014027081A1 Trisubstituted pyrido[2,3-d]pyrimidines, methods for preparing same and therapeutic uses thereof | 
| 02/20/2014 | WO2014026997A1 2,3-benzodiazepines | 
| 02/20/2014 | WO2014026928A1 Process for manufacturing benzoxazinones | 
| 02/20/2014 | WO2014026893A1 Carbamat-benzoxazinones | 
| 02/20/2014 | WO2014026845A1 Carbamates | 
| 02/20/2014 | WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | 
| 02/20/2014 | WO2014026243A1 Vegfr3 inhibitors | 
| 02/20/2014 | WO2013188771A3 Catalytic c-h bond activation | 
| 02/20/2014 | WO2013170068A3 Nuclear transport modulators and uses thereof | 
| 02/20/2014 | US20140051862 5-membered ring heteroaromatic derivatives having npy y5 receptor antagonistic activity | 
| 02/20/2014 | US20140051729 Compositions and methods for treating degenerative muscle conditions | 
| 02/20/2014 | US20140051727 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 
| 02/20/2014 | US20140051709 Compositions and Methods for Treating Myotonic Dystrophy Type 1 | 
| 02/20/2014 | US20140051703 Thiopyrimidine-based compounds and uses thereof | 
| 02/20/2014 | US20140051694 Aminooxazole Inhibitors of Cyclin Dependent Kinases | 
| 02/20/2014 | US20140051691 Oxazine derivatives and a pharmaceutical composition for inhibiting bace1 containing them | 
| 02/20/2014 | US20140051683 7-substituted indole mcl-1 inhibitors | 
| 02/20/2014 | US20140051682 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators | 
| 02/20/2014 | US20140051681 Mst1 kinase inhibitors and methods of their use | 
| 02/20/2014 | US20140051679 Kinase inhibitors and method of treating cancer with same | 
| 02/20/2014 | US20140051676 Triazine-oxadiazoles | 
| 02/20/2014 | US20140051673 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same | 
| 02/20/2014 | US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions | 
| 02/20/2014 | US20140051629 Modulators of the gpr119 receptor and the treatment of disorders related thereto | 
| 02/19/2014 | EP2698369A1 Benzopyrone derivative and use thereof | 
| 02/19/2014 | EP2697240A1 Glycoside derivatives and uses thereof | 
| 02/19/2014 | EP2697220A1 Chromenone compounds as pi 3 -kinase inhibitors for the treatment of cancer | 
| 02/19/2014 | EP2697219A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists | 
| 02/19/2014 | EP2697209A1 Method for the preparation of substituted oxazolidinones | 
| 02/19/2014 | EP2697208A1 1,3 oxazines as bace1 and/or bace2 inhibitors |